Physician

Matthew Charles Schwartz, MD

According to 2025 Medicare claims, Matthew Schwartz, MD (NPI: 1790986339) practices adult congenital heart disease in the Charlotte-Concord-Gastonia, NC-SC market, with the plurality of this provider's patient population coming from Mecklenburg, NC. This provider's primary affiliated billing organization is CAROLINAS PHYSICIANS NETWORK INC. (NPI: 1881624807; TIN: 561667838) and primary practice location at 28203-5812. Schwartz is affiliated with the Carolinas HealthCare System ACO, LLC (ACO ID: A3675), participating under the MSSP model.

Schwartz's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 13 traditional Medicare patients, billed 51 HCPCS/CPT codes, and received $3,390 in Medicare payments. Part D data shows 49 prescription claims totaling $9,433 in drug costs. Open Payments data shows 9 records totaling $11,830. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $5,507 and ending at $3,390. Concurrently, Part D prescription costs have risen steadily, from $152 to $9,433. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$4.6K$9.1K2017 Medicare payment: $5,507 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $3,128 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $9,138 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $8,309 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $4,083 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $6,211 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $3,390 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
20171459$5,507
20181147$3,128
201921115$9,138
2020N/RN/RN/R
20211982$8,309
20221848$4,083
20231754$6,211
20241351$3,390

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$4.7K$9.4K2015 Drug cost: $152 (USD; Tot_Drug_Cst)2016 Drug cost: $78 (USD; Tot_Drug_Cst)2017 Drug cost: $121 (USD; Tot_Drug_Cst)2018 Drug cost: $994 (USD; Tot_Drug_Cst)2019 Drug cost: $4,826 (USD; Tot_Drug_Cst)2020 Drug cost: $1,611 (USD; Tot_Drug_Cst)2021 Drug cost: $6,369 (USD; Tot_Drug_Cst)2022 Drug cost: $5,112 (USD; Tot_Drug_Cst)2023 Drug cost: $4,976 (USD; Tot_Drug_Cst)2024 Drug cost: $9,433 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/R13$152
20161116$78
20171324$121
20181228$994
2019N/R55$4,826
20201455$1,611
20211246$6,369
2022N/R37$5,112
2023N/R33$4,976
2024N/R49$9,433

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Part B summary data is connected for 2024, but public code-level payment amounts are not available, so a Top 5 by total payments cannot be shown.

Top 5 Part D drugs in 2024

By total drug costs.

Part D summary data is connected for 2024, but public drug-level costs are not available, so a Top 5 by total drug costs cannot be shown.

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.5$162Abbott Laboratories
Research PaymentsReported research-related payment or transfer-of-value amount.4$11,668W. L. Gore & Associates, Inc.
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Matthew Charles Schwartz, MD?

Tedicare shows public-source Medicare data for Matthew Charles Schwartz, MD (NPI 1790986339), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Matthew Charles Schwartz, MD have ACO affiliation data?

Matthew Charles Schwartz, MD is shown with ACO affiliation data for Carolinas HealthCare System ACO, LLC (MSSP, ACO ID A3675).

What billing organization is linked to Matthew Charles Schwartz, MD?

Matthew Charles Schwartz, MD is linked to CAROLINAS PHYSICIANS NETWORK INC. (billing NPI 1881624807) in the available physician profile data.

Does Matthew Charles Schwartz, MD have Open Payments data?

Matthew Charles Schwartz, MD has 9 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.